No Fee Unless We Win:

BCH Lead Outside Counsel in Risperdal Case Awarded $15.5 Million

The Commonwealth of Kentucky Attorney General’s office announced a $15.5 million dollar settlement with Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, over allegations that Janssen misled Kentucky consumers about its drug Risperdal and marketed the drug for purposes other than that approved by the FDA.

Janssen and Johnson & Johnson put patients at risk when they marketed Risperdal without disclosing the drug’s known side effects,” Attorney General Jack Conway said in the December 23, 2015 announcement. “These side effects were even more harmful to children and elderly patients.”

Bailey Cowan Heckaman PLLC represented Kentucky as lead outside counsel in the case. Including this settlement, BCH has amassed over $159 million in consumer protection judgments and settlements against Janssen over the marketing and promotion of its antipsychotic drug Risperdal. In the Kentucky case, Tad Thomas of the Thomas Law Offices served as BCH’s co-counsel. The Attorney Fees & Expenses for this case totaled $2,244,647

Attorney General Conway’s press release concerning the Kentucky Risperdal settlement is available here.

Share This Story
If you found this article helpful your friends might too! Please consider sharing this story to your social media channels by tapping the buttons below. 
Begin Your Journey to Justice Today

No Fee Unless We Win:
Quick Links
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram